|
SLC25A1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.248620E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.418820E-04 |
| Normal-vs-Stage2 |
1.639940E-04 |
| Normal-vs-Stage3 |
2.160300E-02 |
| Normal-vs-Stage4 |
1.332340E-02 |
| Stage1-vs-Stage2 |
3.918200E-01 |
| Stage1-vs-Stage3 |
5.482200E-01 |
| Stage1-vs-Stage4 |
7.680400E-01 |
| Stage2-vs-Stage3 |
1.969780E-01 |
| Stage2-vs-Stage4 |
7.370000E-01 |
| Stage3-vs-Stage4 |
5.247000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.178700E-03 |
| Normal-vs-AfricanAmerican |
5.68850000437493E-08 |
| Normal-vs-Asian |
5.192900E-04 |
| Caucasian-vs-AfricanAmerican |
2.041400E-04 |
| Caucasian-vs-Asian |
4.784900E-03 |
| AfricanAmerican-vs-Asian |
4.630800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.980120E-03 |
| Normal-vs-Female |
7.99720000000947E-05 |
| Male-vs-Female |
1.342250E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.444760E-03 |
| Normal-vs-Extreme_Weight |
1.262200E-03 |
| Normal-vs-Obese |
4.321000E-03 |
| Normal-vs-Extreme_Obese |
3.156400E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.586600E-01 |
| Normal_Weight-vs-Obese |
6.233000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.711600E-01 |
| Extreme_Weight-vs-Obese |
8.723200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.396200E-01 |
| Obese-vs-Extreme_Obese |
8.927000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.829400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.34879999999604E-05 |
| Normal-vs-Age(61-80Yrs) |
1.982790E-03 |
| Normal-vs-Age(81-100Yrs) |
1.615900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.560220E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.918800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.551990E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.459800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.291000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.058400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.922110E-02 |
| Normal-VS-Type2 PRCC |
2.25210000004417E-06 |
| Normal-VS-KIRP CIMP |
1.584040E-01 |
| Normal-VS-Unclassified PRCC |
2.780200E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.660220E-03 |
| Type1 PRCC-VS-KIRP CIMP |
9.259800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.820000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.654620E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.573800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.419600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.686000E-02 |
| Normal-vs-N1 |
1.502360E-03 |
| Normal-vs-N2 |
7.900000E-02 |
| N0-vs-N1 |
2.320400E-01 |
| N0-vs-N2 |
6.476400E-01 |
| N1-vs-N2 |
9.091600E-01 |
|
|
